secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2026-06-09T20:31:00+00:00
Accession:  0001437749-26-020005
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals reports stockholder voting results from 2026 annual meeting
--------------------------------------------------------------------------------

- Jenn Adams elected director with 13,370,948 votes for, 2,149,317 withheld.
- Charles J. Casamento elected director with 9,925,548 votes for, 5,594,717 withheld.
- Ratification of Grant Thornton LLP as auditor passed with 16,942,328 for, 3,236,671 against.
- Broker non-votes on director elections totaled 4,664,035.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/0001437749-26-020005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/eton20260409_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer